Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Andrews

Showing results (71-80 of 368) with videos related to

Pageof 37
Sort By:
The Journal of Antimicrobial Chemotherapy|March 1, 1984
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agentsR Wise, J M Andrews, G Danks
The Journal of Antimicrobial Chemotherapy|December 1, 1981
SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agentsR Wise, J M Andrews, J Hancox
Alimentary Pharmacology & Therapeutics|May 8, 2014
Commentary: The association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's diseaseS-Y J Ooi, J M Andrews
The Journal of Antimicrobial Chemotherapy|November 1, 1994
The in-vitro activity of FK-037, a new broad spectrum injectable cephalosporinR Wise, J M Andrews, D Thornber
Thorax|April 1, 1995
Co-amoxiclav levels in bronchial mucosaD Honeybourne, J M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|November 1, 1986
The postantibiotic effect of imipenemN Manek, J M Andrews, R Wise
Antimicrobial Agents and Chemotherapy|February 1, 1995
Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacinJ Child, J M Andrews, R Wise
Lancet (London, England)|May 2, 1987
Ciprofloxacin penetration into lungsD Honeybourne, R Wise, J M Andrews
Antimicrobial Agents and Chemotherapy|August 1, 1986
In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsN Manek, J M Andrews, R Wise
Antimicrobial Agents and Chemotherapy|December 1, 1984
In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agentsR Wise, C Cross, J M Andrews
Pageof 37

Showing results (71-80 of 368) with videos related to

Sort By:
Pageof 37
The Journal of Antimicrobial Chemotherapy|March 1, 1984
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agentsR Wise, J M Andrews, G Danks
The Journal of Antimicrobial Chemotherapy|December 1, 1981
SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agentsR Wise, J M Andrews, J Hancox
Alimentary Pharmacology & Therapeutics|May 8, 2014
Commentary: The association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's diseaseS-Y J Ooi, J M Andrews
The Journal of Antimicrobial Chemotherapy|November 1, 1994
The in-vitro activity of FK-037, a new broad spectrum injectable cephalosporinR Wise, J M Andrews, D Thornber
Thorax|April 1, 1995
Co-amoxiclav levels in bronchial mucosaD Honeybourne, J M Andrews, R Wise
The Journal of Antimicrobial Chemotherapy|November 1, 1986
The postantibiotic effect of imipenemN Manek, J M Andrews, R Wise
Antimicrobial Agents and Chemotherapy|February 1, 1995
Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacinJ Child, J M Andrews, R Wise
Lancet (London, England)|May 2, 1987
Ciprofloxacin penetration into lungsD Honeybourne, R Wise, J M Andrews
Antimicrobial Agents and Chemotherapy|August 1, 1986
In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agentsN Manek, J M Andrews, R Wise
Antimicrobial Agents and Chemotherapy|December 1, 1984
In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agentsR Wise, C Cross, J M Andrews
Pageof 37